Aim: The main objectives of this study were to evaluate the incidence, imaging characteristics, and prognosis of parenchymal brain metastases originating in thyroid cancer.
Introduction: While thyroid cancer is a relatively common type of cancer, it is usually highly curable.1 Brain metastases from thyroid cancer are rare and their imaging appearance has not been well defined.2
Methods: Review of case records of thyroid cancer patients within the IPO Porto data base from 2005 to 2015 was conducted in order to identify the patients with thyroid cancer and evidence of brain metastases.
Results: We identified 3175 patients with thyroid cancer, with only five having evidence of brain metastases (two from papillary thyroid cancer, two from follicular thyroid cancer and one from poorly differentiated thyroid cancer). At the time of brain metastases detection, 100% of the patients had concurrent lymph node metastases, 80% lung metastases and 60% osseous metastases. Of those brain metastases, 60% were multifocal and 40% presented as partially cystic/necrotic. Of the two cases in which the patients died, the median overall survival after brain metastasis detection was less than one year.
Conclusion: Brain metastasis from thyroid cancer remains a rare phenomenon that most frequently occurs in the setting of widely disseminated lymph node disease. The imaging appearance is highly variable and the prognosis is poor.